Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
The effect of sublethal concentrations of antibiotics on the serum sensitivity of Pseudomonas aeruginosa was examined. Cefepime, ceftazidime, and imipenem but not amikacin nor ciprofloxacin increased the serum bactericidal activity of pooled normal human serum. Killing was both serum- and antibiotic dose-dependent. Increased sensitivity to the bactericidal action of serum in the presence of cefepime was observed for several different clinical isolates. With the use of C8-deficient sera, the late components of the complement pathway were shown to be essential for bacterial killing. A significant increase in the amount of [125I]C9 based on bacterial mass was observed with bacteria incubated with cefepime compared with non-antibiotic- or amikacin-treated controls. No major change in the amount of type of lipopolysaccharide was observed when cefepime-treated and control bacteria were compared. The data show that cefepime and other cephalosporins at sublethal concentrations increase the complement-mediated bactericidal activity of serum against P. aeruginosa.
Darveau
R P
RP
Anti-Infective Therapy Group, Oncogen Corporation, Seattle, Washington 98121.
Cunningham
M D
MD
D000583:Amikacin / Q000494:pharmacology; D001770:Blood Bactericidal Activity / Q000187:drug effects*; D000077723:Cefepime; D002442:Ceftazidime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D003186:Complement C9 / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000032:analysis; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000276:immunology; D015610:Serum Bactericidal Test
D002511:Cephalosporins; D003186:Complement C9; D008070:Lipopolysaccharides; D002939:Ciprofloxacin; D015378:Imipenem; D000077723:Cefepime; D000583:Amikacin; D003165:Complement System Proteins; D002442:Ceftazidime